Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
01/2007
01/09/2007US7160993 Nucleic acids encoding PRO4400 polypeptides
01/09/2007US7160982 Peptide substrate identified by type BoNT/B botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors
01/09/2007US7160861 Methods of inducing IL-10 production
01/09/2007US7160859 administering compounds/agents that inhibit Mst1 or the Mst1 kinase pathway such as Caspase 3 inhibitors; assay system for screening potential compounds or agents effective to modulate Mst1 activity; transgenic animal wherein Mst1 expression or activity is enhanced
01/09/2007US7160710 Fungamyl-like alpha-amylase variants
01/09/2007US7160705 Arginine repressor deficient strain of coryneform bacterium and method for producing L-arginine
01/09/2007US7160536 Radiolabelled metal transport proteins as imaging agents
01/09/2007CA2411019C Particles for immunoassays and methods for treating the same
01/09/2007CA2365697C Improved methods for recombinant peptide production
01/09/2007CA2236751C Method for producing a correctly folded, biological active recombinant protein
01/04/2007WO2007002676A2 Liquid protein markers for native gel electrophoresis
01/04/2007WO2007002482A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease
01/04/2007WO2007000972A1 Novel use as tag
01/04/2007WO2006124152A3 Method for using a static electric field to induce crystallization and to control crystal form
01/04/2007WO2006106348A3 Protein glycosylation
01/04/2007WO2006068480A3 Protein hydrolysate enriched in peptides inhibiting dpp-iv and their use
01/04/2007WO2006063150A3 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
01/04/2007WO2006017824A3 Igf-bp3-related methods for inhibiting tumor growth
01/04/2007US20070005255 Synthetic active peptide fragments
01/04/2007US20070004905 Solid-phase peptide synthesis and agent for use in such synthesis
01/04/2007US20070003567 Composition and methods for enhancing immunogenecity of antigens
01/04/2007US20070000784 Electroosmotic flow controller
01/04/2007US20070000781 Providing a microfluidic biochip, applying a motive force selected from pressure, electroosmotic force, capillary action, and centrifugal force, thereby generating flow; directing a biomolecule from a source to the polymer by employing the flow; reacting the biomolecule with the biomolecule-immobilizing
01/04/2007CA2608474A1 Compositions and methods for immunomodulation in an organism
01/03/2007EP1739093A1 Separation of plasma proteins
01/03/2007EP1739089A1 Method of separating protein
01/03/2007EP1737983A2 Method of inducing immunity against stratum corneum chymotrytic enzyme
01/03/2007EP1737982A2 Nucleic-acid programmable protein arrays
01/03/2007EP1737976A2 Genetic markers for skatole metabolism
01/03/2007EP1685245A4 A process of making transgenic mammals that produce exogenous proteins in milk and transgenic mammals produced thereby
01/03/2007EP1448789A4 Device and methods for directed synthesis of chemical libraries
01/03/2007EP1373302B1 Method for purification of molecules using unbranched terminal alkyldiols
01/03/2007EP1171405B1 Functionalised solid support for alpha-oxoaldehyde synthesis
01/03/2007EP1107773B1 Method for detection of legionella bacteria employing purified antigen-specific antibodies
01/03/2007EP0871474B1 Generation of human insulin
01/03/2007CN1890367A Surfactant-tolerant cellulase and method of converting the same
01/03/2007CN1890257A Virus filtration of liquid factor vii compositions
01/03/2007CN1889937A Glycopegylated factor IX
01/03/2007CN1888066A Production process of recombinant human horny cell growth factor-2
01/03/2007CN1888065A Expression method of recombinant Periplaneta americana allergen protein
01/03/2007CN1293096C Method for synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide
01/03/2007CN1293092C Method for separating lacti-streptocin from fermentation liquid of lacti-galactococcus
01/03/2007CN1293091C Treating solution containing aluminium ion for staining protein and staining method using the same
01/02/2007US7157565 Far red shifted fluorescent proteins
01/02/2007US7157562 Bioprocess for the production of recombinant anti-botulinum toxin antibody
01/02/2007US7157557 Generation of preferential genetically engineered protein; obtain cells, transform with vector containing protein, express vector, recover protein
01/02/2007US7157556 Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use
01/02/2007US7157546 Water-soluble polymer alkanals
01/02/2007US7157529 Multi-layered macromolecules and methods for their use
01/02/2007US7157500 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality
01/02/2007US7157439 a cellulose and a HoxB3 homeotic nucleic acid or protein; improved neovascularization
01/02/2007US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases
01/02/2007US7157418 Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders
01/02/2007US7157277 Factor VIII remodeling and glycoconjugation of Factor VIII
01/02/2007US7157260 Enzymatic polypeptide for propagating plant in iron deficient soils
01/02/2007US7157241 Dipeptidyl peptidase IV (DPPIV); given sequences; homology with family of prolyl oligopeptidases; drug screening for enzyme inhibitors for DPPIV which could treat reproductive, inflammatory and metabolic disorders
01/02/2007US7156971 Capillary array and electrophoresis apparatus, and methods
01/02/2007CA2236900C Igg separation medium and novel protein a variant
12/2006
12/30/2006CA2551085A1 Ionization modifier for mass spectrometry
12/29/2006CA2551345A1 Process for separating fibrinogen proteins, factor xiii and biological glue from a soluble plasma fraction and for preparing lyophilized concentrates of the said proteins
12/28/2006WO2006136296A1 Method and devices for forming a plurality of wells on a gel
12/28/2006WO2006047357A3 Human ly6-big molecules and methods of use
12/28/2006WO2006023452A3 Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases
12/28/2006WO2005089409A3 Sensor constructs and detection methods
12/28/2006WO2005058243A3 Methods for treating cancer using vascular endothelial cell growth inhibitor vegi-192a
12/28/2006WO2005054295A3 Therapeutic and diagnostic anti-hsp 70 antibodies
12/28/2006WO2004054517A3 Compositions and methods for inhibiting tumor growth and metastasis
12/28/2006US20060294601 Compositions, organisms and methodologies employing a novel human kinase
12/28/2006US20060293372 Beta-sheet mimetics and methods relating to the use thereof
12/28/2006US20060292670 Nell peptide expression systems and bone formation activity of nell peptide
12/28/2006US20060292563 Methods of diagnosing & treating diabetes and insulin resistance
12/28/2006US20060289309 Microchemical system
12/28/2006CA2612052A1 Method and devices for forming a plurality of wells on a gel
12/27/2006EP1735453A2 Fluorescent signal emitting live cell biosensor molecules and dyes for detection and quantification of protein activities
12/27/2006EP1735346A1 Method for preparing modified collagen outside a host cell
12/27/2006EP1735334A1 Set1 proteins and uses therefor
12/27/2006EP1735333A2 Chimeric cannulae proteins, nucleic acids encoding them and methods for making and using them
12/27/2006EP1735090A1 Reversible binding surface
12/27/2006EP1735082A1 Materials, methods, and systems for separating and identifying proteins from mixtures
12/27/2006EP1734971A1 Polymer-based sustained release device
12/27/2006EP1734827A2 Methods and compositions for treatment of diseases associated with aberrant microsatellite expansion
12/27/2006EP1242594B1 Method for isolation of rna from fixed paraffin-embedded tissue specimens
12/27/2006EP1210449B1 Methods for the detection, analysis and isolation of nascent proteins
12/27/2006EP1095056B1 High pressure refolding of protein aggregates and inclusion bodies
12/27/2006EP1028742B1 Apo b, annexin v and tubulin : medical, diagnostic and purification uses for hcv
12/27/2006CN1886421A Hemiasterlin derivatives and uses thereof
12/27/2006CN1886420A Self-assembling split-fluorescent protein systems
12/27/2006CN1291999C Membrane process for extracting soybean protein peptide and technique of deep processing byproduct
12/26/2006US7153944 High affinity integrin polypeptides and uses thereof
12/26/2006US7153942 Polypeptide for use in the treatment of inflammation, rheumatoid arritis, psoriasis, and diabetic retinopathy
12/26/2006US7153936 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity
12/26/2006US7153933 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same
12/26/2006US7153864 Polyglutamic acid-camptothecin conjugates and methods of preparation
12/26/2006US7153836 Having 1-4 hydrophobic C 10-24 aliphatic, saturated or unsaturated hydrocarbon residue moieties covalently bound to a protein with a hedgehog N-terminal domain; includes auxiliary substances, detergents, stabilizers, matrix materials, suramin, heparin, anionic polysaccharides and/or sequestering agents
12/26/2006US7153827 Produced by recombinant techniques; stimulating angiogenesis for wound healing and for vascular tissue repair
12/26/2006US7153668 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disoders
12/26/2006US7153426 Separation speed increased without sacrificing selectivity; charged group (carboxy, sulfonate, amino) covalently attached to a hydroxyl group on a cellulose membrane; modification of pores to alter charge and size; permeability versus sieving performance is enhanced; protein separations
12/21/2006WO2006135740A1 Pegylated hemoglobin and albumin and uses thereof
12/21/2006WO2006134390A2 Method for diagnosing neurodegenerative disease
12/21/2006WO2006134173A2 Selective reduction and derivatization of engineered proteins comprising at least one non-native cysteine